Texas Biomedical Research Institute

We applaud Sabin Vaccine Institute, the Rwandan government and their partners to quickly launch a clinical trial of Sabin's investigational #Marburg vaccine to help with the outbreak there. We are proud to have partnered with Sabin and Biomedical Advanced Research and Development Authority (BARDA) on early studies to help advance the vaccine to human trials. Seeing a vaccine candidate that has come through our labs helping in an emergency goes to the heart of our mission as an Institute -- eradicating the threat of infectious diseases. https://lnkd.in/g5xuhwvH

We are delighted to welcome Erika Wright-McAfee MLAS, DVM to the team at Texas Biomed and SNPRC! Read more about her passion for animal medicine and her career journey to Texas. #veterinarian #veterinarymedicine #SATX https://lnkd.in/gqJAG5HC

Members of the Texas Developmental-Center for AIDS Research (Texas D-CFAR) gathered at Texas Biomed and online today for a Mini Symposium to share ongoing #HIV research, ranging from vaccines and therapies to interactions with other diseases and substances. Texas D-CFAR aims to help end the HIV epidemic in Texas through research, community engagement and training the next generation of HIV researchers and clinicians. The Center is based at Baylor College of Medicine, The University of Texas Health Science Center at Houston (UTHealth Houston) and Texas Biomedical Research Institute. A key feature of the Center is providing opportunities to share research, exchange ideas and catalyze collaborations across #Texas. Great to have D-CFAR core leaders from all three institutes here today, including Jason Kimata, Thomas Giordano, Diane Santa Maria, Mahesh Mohan and Deepak Kaushal along with Texas Biomed President/CEO Larry Schlesinger. Dr. Giordano gave an overview of D-CFAR before the research presentations.

Thanks to members of the Founder's Council for visiting Texas Biomed this week for a behind-the-scenes tour! Founder's Council is a unique way to get involved in #SATX #science and support the mission of Texas Biomed. Learn more: https://lnkd.in/gweRsqsU w/ Sara Wise

Today in #IAmTexasBiomed, meet Kiara Mermea, one of our passionate animal caretakers at Texas Biomed and Southwest National Primate Research Center. Our staff is incredibly dedicated to the health and welfare of our animals and are the foundation of making Texas Biomed such a unique and inspiring place to work. Together, #WeAreTexasBiomed. Learn more: https://lnkd.in/dtpYi-cZ #animalcare #veterinarycare #biomedical #science #SATX #SanAntonio #inclusiveworkplace

ICYMI: The full season of "Tom Slick, Mystery Hunter" - a dramatized podcast about Texas Biomed's founder Tom Slick, Jr. - is out now. The 8-episode series features Owen Wilson voicing Tom Slick and Sissy Spacek voicing his daughter. We are especially excited to highlight the final Fact v. Fiction episode, which reveals what the writers made up to weave an enthralling tale versus the real facts of Tom's life. The truth might surprise you! The episode features interviews with members of Tom's family -- niece/biographer Catherine Nixon Cooke and son Charles Slick -- as well as Texas Biomed President/CEO Larry Schlesinger and Southwest Research Institute President Adam Hamilton. We are delighted that the podcast is sharing Tom's enduring legacy on human health by investing in #science and establishing several research institutes here in #SanAntonio. Tom was not just a visionary with big ideas – he acted on them. He made them happen. We at Texas Biomed strive every day to continue in his footsteps. Enjoy the listen! #SATX #visionary https://lnkd.in/gwHcKrUe

A human cell model of the lung's most important immune cell, the #alveolar #macrophage, developed at Texas Biomed is being used by other researchers around the world, and they are making some pretty exciting discoveries! Recently, collaborators were able to determine exactly how the immune-signaling protein, TNF, is critical to protect against #tuberculosis, but not for other respiratory illnesses. This finding is causing scientists to rethink TNF's role in the body. The discovery was made possible through a combination of genetic studies of real patients and several cellular models, including the alveolar macrophage-like (AML) model developed by Texas Biomed Professor, President/CEO Larry Schlesinger and Staff Scientist Susanta Pahari. Read more about the research recently published in Nature and about the AML model! w/ Anna-Lena Neehus, Laboratory of Human Genetics of Infectious Diseases, The Rockefeller University & University of Antioquia #innovation #cellmodel #research #science #collaboration https://lnkd.in/geimJeaU

Are you a scientist studying #tuberculosis or a student interested in #TBresearch or #publichealth? A healthcare provider, family member or patient advocate working with patients with #TB? We invite you to join us at the IN-TRAC Patient Conference to hear directly from families affected by TB. Gain insights and inspiration from parents of adolescents with TB and young adults living with TB. You’ll learn about how they deal with the stigma surrounding their diagnosis, their daily routines and more. The IN-TRAC Patient Conference will take place Oct. 31 at noon at Texas Biomed in San Antonio. Attend in person or virtually. Hosted by Larry Schlesinger, Texas Biomed; Blanca I Restrepo, The University of Texas Health Science Center at Houston (UTHealth Houston) and Lisa Armitige, Heartland National TB Center. #SATX #Texas #TRAC w/ The National Institutes of Health, Graduate School of Biomedical Sciences at The University of Texas Health Science Center San Antonio, UTSA College of Sciences, UT Southwestern Medical Center, Baylor College of Medicine Learn more and register here --> https://lnkd.in/ggbkrXCx

Members of Texas Biomed's Community Outreach Club recently volunteered at the Texas Diaper Bank, which collects donations of diapers for babies, feminine products for women and adult diapers for seniors. It is rewarding to give back to the #SATX community and #volunteer as a team!

Texas Biomed Professor Smriti Mehra and her team are investigating a therapy for #tuberculosis that is already helping fight #cancer. The therapy involves briefly inhibiting an immune system protein called IDO. Since many people with #HIV can be susceptible to other infections like TB, it is important to know if inhibiting IDO affects antiretroviral therapy. This preclinical study is an important step towards human clinical trials. #TB #preclinical #biomedical #research https://lnkd.in/g5CXUCAx